Sotera Health Company Q1 2026 Earnings Call Summary
Sotera Health reported mixed performance across its segments in Q1 2026. Sterigenics saw growth driven by pricing and volume/mix, while Nordion's revenue increase was due to Cobalt-60 harvest timing rather than market shifts. Nelson Labs remained stable amid ongoing challenges from the Expert Advisory Services business.
Tickers: $SHC
Topics: Earnings Legal Milestone Operational Performance Revenue Growth Strategic Guidance